Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHAT | P28329 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | RELA | Q04206 | 1/20 | 0.56 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.54 |
| ▸ | FBP1 | P09467 | 1/20 | 0.53 |
| ▸ | MAOB | P27338 | 6/20 | 0.49 |
| ▸ | MAOA | P21397 | 3/20 | 0.45 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.45 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.45 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL321041 | 1.00 | CHAT (0.58) | CHATCYP1A2CYP2C9RELACHRM5 | |
| SCHEMBL771273 | 1.00 | CHAT (0.58) | CHATCYP1A2CYP2C9RELACHRM5 | |
| SCHEMBL29983358 | 1.00 | CHAT (0.58) | CHATCYP1A2CYP2C9RELACHRM5 | |
| SCHEMBL699364 | 0.85 | CHAT (0.67) | CHATCYP1A2CYP2C9RELACHRM5 | |
| SCHEMBL699365 | 0.85 | CHAT (0.67) | CHATCYP1A2CYP2C9RELACHRM5 | |
| SCHEMBL335941 | 0.83 | CNR2 (0.50) | RELAFBP1MAOBMAOANFE2L2 | |
| SCHEMBL29033283 | 0.83 | CNR2 (0.50) | RELAFBP1MAOBMAOANFE2L2 | |
| SCHEMBL335942 | 0.83 | CNR2 (0.50) | RELAFBP1MAOBMAOANFE2L2 | |
| SCHEMBL575075 | 0.81 | — | — | |
| SCHEMBL11471054 | 0.81 | CYP1A2 (0.61) | CHATCYP1A2CYP2C9RELACHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9000077-B2 | Phosphazene compound having vinyl group, resin composition containing the same, and circuit board manufactured from the same | Elite Material Co., Ltd. (TW) | 2015-04-07 | — | — | US | claimed |
| US-20140323624-A1 | PHOSPHAZENE COMPOUND HAVING VINYL GROUP, RESIN COMPOSITION CONTAINING THE SAME, AND CIRCUIT BOARD MANUFACTURED FROM THE SAME | Elite Material Co., Ltd. (TW) | 2014-10-30 | — | — | US | claimed |
| US-20100179291-A1 | LONG CHAIN-BRANCHED ETHYLENE-ALPHA OLEFIN COPOLYMER | LG CHEM, LTD. (KR) | 2010-07-15 | — | — | US | claimed |
| US-20100087609-A1 | ETHYLENE ALPHA-OLEFIN COPOYMER | LG CHEM, LTD. (KR) | 2010-04-08 | — | — | US | claimed |
| EP-2147027-A2 | LONG CHAIN-BRANCHED ETHYLENE-ALPHA OLEFIN COPOLYMER | LG Chem, Ltd. (KR) | 2010-01-27 | — | — | EP | claimed |
| WO-2008140205-A1 | ETHYLENE ALPHA-OLEFIN COPOLYMER | LG CHEM, LTD. (KR) | 2008-11-20 | — | — | WO | claimed |
| WO-2008140280-A2 | LONG CHAIN-BRANCHED ETHYLENE-ALPHA OLEFIN COPOLYMER | LG CHEM, LTD. (KR) | 2008-11-20 | — | — | WO | claimed |
| CN-116535839-B | Resin composition and product thereof | 台光电子材料(昆山)股份有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-118251477-A | Method and system for decontaminating pyrolysis oil using modular units | SABIC环球技术有限责任公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-117355521-A | Heteroaryl inhibitors of plasma kallikrein | 武田药品工业株式会社 | 2024-01-05 | — | — | CN | disclosed |
| US-11851562-B2 | Resin composition and article made therefrom | ELITE ELECTRONIC MATERIAL (KUNSHAN) CO., LTD. (CN) | 2023-12-26 | — | — | US | disclosed |
| CN-114874084-B | Preparation method of bupropion hydrochloride impurity F | 浙江普洛家园药业有限公司 | 2023-12-19 | — | — | CN | disclosed |
| CN-116535839-A | Resin composition and product thereof | 台光电子材料(昆山)有限公司 | 2023-08-04 | — | — | CN | disclosed |
| US-6337328-B1 | TREATMENT OF SEXUAL DYSFUNCTION WITH 2-(3-CHLOROPHENYL)-2-HYDROXY-3,5,5-TRIMETHYL-MORPHOLINOL, 1-(3-CHLOROPHENYL)-2-((1,1-DIMETHYLETHANOL)AMINO)-1-PROPANOL, AND | SEPRACOR, INC. | 2002-01-08 | — | — | US | disclosed |
| US-6310078-B1 | MODULATING ERYTHROPOIETIN RECEPTOR, TREATING DISEASE OR CONDITION MEDIATED BY SAID RECEPTOR | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2001-10-30 | — | — | US | disclosed |
| US-6306911-B1 | ENZYME INHIBITORS | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2001-10-23 | — | — | US | disclosed |
| WO-2001056560-A1 | SUBSTITUTED AMINO ACIDS AS NEUTRAL SPHINGOMYELINASE INHIBITORS | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2001-08-09 | — | — | WO | disclosed |
| EP-1073623-A1 | SUBSTITUTED AMINO ACIDS AS ERYTHROPOIETIN MIMETICS | Ortho-Mcneil Pharmaceutical, Inc. (US) | 2001-02-07 | — | — | EP | disclosed |
| WO-1999054279-A1 | SUBSTITUTED AMINO ACIDS AS ERYTHROPOIETIN MIMETICS | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 1999-10-28 | — | — | WO | disclosed |
| EP-0197274-A1 | Process for the preparation of substituted styrenes | BAYER AG (DE) | 1986-10-15 | — | — | EP | disclosed |